查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553569

基因面板市场规模、份额、趋势分析报告：按产品/服务、按方法、按设计、按应用、按最终用途、按地区、细分市场预测，2024-2030

Gene Panel Market Size, Share & Trends Analysis Report By Product & Services (Test Kits, Testing Services), By Technique (Amplicon Based), By Design, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

基因面板市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球基因面板市场规模将达到87.3亿美元，2024年至2030年复合年增长率为17.6%。

先天性疾病的增加和全球癌症患者数量的空前增加预计将推动市场的发展。染色体异常的早期诊断可以预后诊断和治疗措施，从而可以延缓症状并提高生活品质。

此外，对遗传性、基因筛检、个人化医疗、风险分析和预后预测的日益增长的需求预计将推动市场的发展。为了了解疾病的遗传倾向，需要对特定的基因簇进行定序和分析。此面板有助于确定已知导致疾病的特定基因的序列。有许多针对特定条件的预先设计的面板，也可以自订。人们也持续进行研究工作，开发新的基因组，以有效诊断各种遗传疾病。

例如，INVIEW Liquid Biopsy Onco-profiling 是一个综合癌症基因组，用于使用血液等液态生物检体样本进行测试。还可以根据您的具体要求自订基因面板。例如，QIAseq 多模式自订面板是一个可自订的基因面板，可让您从单一样本输入中分析变异 DNA、RNA 融合和基因表现模式。

COVID-19 大流行严重扰乱了有效医疗保健服务的提供，包括遗传咨询和基因检测服务。在美国，正在努力确保恢復基因检测，至少是胚胎着床前筛检。但加强癌症基因筛检也是世界各地癌症协会使命的一部分。

此外，许多研究人员和临床医生认为，迫切需要进行基因筛检以降低遗传性疾病的死亡率，因此预计在预测期内对基因组的需求将会增加。例如，在美国，出生时就需要对血液样本进行某些遗传、内分泌、代谢、听力和严重先天性心臟疾病的筛检。

基因组市场报告亮点

  • 按产品和服务划分，由于检测套组可以为临床医生、研究人员和公众带来实际好处，检测套组产业在 2023 年占据最大份额。现成的试剂套件和自我管理的诊断试剂套件如今越来越流行。
  • 从技术上来说，由于结果的可靠性，基于杂合反应的方法正处于成长阶段，但这种技术昂贵且耗时。基因组通常设计用于分析多个基因，而杂合反应技术非常适合这种基因组测试概念。
  • 按照设计，2023 年的市场将由预先设计的基因组主导。这是因为在诊断效用方面，预先设计的基因组优于可自订的基因组。
  • 从应用来看，由于癌症患者数量的增加以及各国癌症筛检建议的增加，预计癌症风险评估领域将在预测期内显着增长。
  • 由于基因筛检和早期癌症筛检的需求增加、主要企业的存在、癌症盛行率上升以及新生儿筛检建议的增加，北美将在 2023 年主导全球市场。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 基因组市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 基因组市场分析工具
    • 波特的分析
    • PESTEL分析

第 4 章 基因组市场：按产品/服务分類的估计和趋势分析

  • 细分仪表板
  • 基因组市场：2023 年和 2030 年按产品/服务分類的变化分析
  • 检测套组
  • 测试服务

第五章 基因检测市场：技术预估与趋势分析

  • 细分仪表板
  • 基因组市场：2023 年和 2030 年技术变化分析
  • 基于扩增子的方法
  • 基于混合的方法

第六章 基因组市场：依最终用途分类的估计与趋势分析

  • 细分仪表板
  • 基因组合市场：最终用途变化分析，2023 年和 2030 年
  • 学术研究所
  • 医院和诊断实验室
  • 製药和生物技术公司

第七章 基因组市场：按应用估计和趋势分析

  • 细分仪表板
  • 基因组合市场：2023 年和 2030 年应用变化分析
  • 癌症风险评估
  • 先天性疾病的诊断
  • 药物基因学
  • 其他用途

第八章基因组合市场：区域估计与趋势分析

  • 2023 年及 2030 年基因组市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Agilent Technologies
    • Illumina Inc.
    • Qiagen Inc.
    • Eurofins Genomics
    • Thermo Fisher Scientific, Inc.
    • Foundation Medicine, Inc.
    • Guardant Health, Inc.
    • Cepheid
    • Bio-Rad Laboratories, Inc.
    • Personalis
简介目录
Product Code: GVR-4-68039-977-6

Gene Panel Market Growth & Trends:

The global gene panel market size is expected to reach USD 8.73 billion by 2030, registering to grow at a CAGR of 17.6% from 2024 to 2030 according to a new report by Grand View Research, Inc. A rise in the number of congenital disorders, coupled with an unprecedented increase in the number of cancer cases across the globe, is anticipated to drive the market. Early diagnosis of chromosomal disorders enables timely prognosis and therapeutic steps to be taken so as to retard the symptoms and improve the quality of life.

Furthermore, an increase in hereditary level understanding and a rise in the need for genetic screening, personalized medicine, risk analysis, and prognostics are anticipated to drive the market. A specific group of genes needs to be sequenced and analyzed to understand the genetic predisposition of a disease condition. The panels help in sequencing specific genes that are known to be causative of the disease condition. There are many predesigned panels for particular disease conditions along with options for customization. There also have been consistent research efforts to devise novel gene panels to efficiently diagnose a wide spectrum of genetic disorders.

For instance, INVIEW Liquid Biopsy Onco-profiling is an all-inclusive comprehensive cancer gene panel for examination using liquid biopsy samples like blood. Customizable gene panels are also available that can be customized based on specific requirements. For instance, QIAseq multimodal custom panel is a customizable gene panel that is able to profile variant DNA, RNA fusion, and gene expression patterns from a single sample input.

The COVID-19 pandemic has significantly disrupted the delivery of effective healthcare services, including genetic counseling and genetic testing services. There are efforts across the U.S. to ensure re-igniting genetic testing, at least for pre-implantation screening. However, the ramping up of genetic screening for cancer has also become a part of the mission of cancer societies across the globe.

Moreover, many researchers and clinicians believe that there is a strong necessity for the enforcement of genetic screening procedures to bring down the mortality rate due to genetic disorders, and therefore there will be a rise in the demand for gene panels during the forecast period. For instance, all those born in the U.S. are compulsorily screened using a blood sample for certain genetic, endocrine, metabolic, hearing, and critical congenital heart disorders.

Gene Panel Market Report Highlights:

  • By products & services, the test kits segment held the largest share in 2023 due to the utilitarian benefits that a test kit could offer to clinicians, researchers, and the normal population. Ready-to-use kits and self-administrable diagnostic kits are increasingly trending these days
  • By technique, the hybridization-based approach is in the growth phase due to the reliability of outcomes, though the technique is expensive and time-consuming. Gene panels are usually designed for the analysis of several genes and the hybridization technique is conducive to this concept of gene panel testing
  • By design, predesigned gene panels dominated the market in 2023. This is because predesigned gene panels are preferred over customizable gene panels for diagnostic utility because predesigned panels are backed by research for outcome reliability
  • By application, the cancer risk assessment segment is expected to grow lucratively during the forecast period due to a rise in the number of cancer cases and increased recommendations for cancer screening across different countries
  • North America dominated the global market in 2023 owing to the increasing demand for genetic screening and early cancer screening, the presence of key players, the rising prevalence of cancer, and rising recommendations for newborn screening

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Gene Panel Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Gene Panel Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Gene Panel Market: Products & Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Gene Panel Market: Products & Services Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Test Kits
    • 4.3.1. Test Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Testing Services
    • 4.4.1. Testing Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Gene Panel Market: Technique Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Gene Panel Market: Technique Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Amplicon Based Approach
    • 5.3.1. Amplicon Based Approach Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Hybridization Based Approach
    • 5.4.1. Hybridization Based Approach Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Gene Panel Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Gene Panel Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Hospital & Diagnostic Laboratories
    • 6.4.1. Hospital & Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Pharmaceutical & Biotechnology Companies
    • 6.5.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Gene Panel Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Gene Panel Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Cancer Risk Assessment
    • 7.3.1. Cancer Risk Assessment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Diagnosis of Congenital Diseases
    • 7.4.1. Diagnosis of Congenital Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Pharmacogenetics
    • 7.5.1. Pharmacogenetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Other Applications.
    • 7.6.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Gene Panel Market: Regional Estimates & Trend Analysis

  • 8.1. Gene Panel Market Share, By Region, 2023 & 2030 (USD Million)
  • 8.2. North America
    • 8.2.1. North America Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacifics
    • 8.4.1. Asia Pacific Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. China
      • 8.4.2.1. China Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Japan Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Australia Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Saudi Arabia
      • 8.6.2.1. Saudi Arabia Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. UAE
      • 8.6.3.1. UAE Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. South Africa
      • 8.6.4.1. South Africa Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Agilent Technologies
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Illumina Inc.
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Qiagen Inc.
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Eurofins Genomics
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Thermo Fisher Scientific, Inc.
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Foundation Medicine, Inc.
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Guardant Health, Inc.
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Cepheid
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. Bio-Rad Laboratories, Inc.
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Personalis
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives